Previously, and in more detail than the present study, we observed a tight and unambiguous inverse correlation between the presence of the fusion oncogene BCR-ABL and the gene expression of HERC1 and HERC2 in newly diagnosed CML patients. The gene discussed is HERC2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.